# Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study

> **NCT03003273** · PHASE3 · TERMINATED · sponsor: **All India Institute of Medical Sciences** · enrollment: 142 (estimated)

## Conditions studied

- Neutropenia, Febrile
- Pediatric Cancer

## Interventions

- **OTHER:** stoppage of antibiotics
- **OTHER:** amoxycillin/clavulanic acid
- **OTHER:** levofloxacin

## Key facts

- **NCT ID:** NCT03003273
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 142 (ESTIMATED)
- **Why stopped:** poor accrual
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003273, "Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03003273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*